WeightWatchers soars after Sequence acquisition

WeightWatchers soared Tuesday after the company said it was getting into the prescription drug weight loss business with the acquisition of Sequence.

WeightWatchers acquires Sequence to offer access to obesity drugs

WeightWatchers jumps into into the prescription weight loss drug

WeightWatchers starts the New Year with self-love in 'Returns

WeightWatchers moves into obesity drug market with Sequence

WeightWatchers (NASDAQ: WW) Announces Acquisition of Sequence in

WeightWatchers Sinks as Eli Lilly Launches Weight-Loss Drug Delivery

Sequence - Overview, News & Similar companies

WW Stock Soars As ​Rising Obesity Drug Market Drives This

WeightWatchers gets into prescription weight loss business

WeightWatchers to buy Sequence, enter weight loss drug market

WeightWatchers acquires Sequence to offer access to obesity drugs